Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells Retraction in /10.3892/ijo.2024.5679

Li,Hang; Li,Dan; Meng,Ning

doi:10.3892/ijo.2017.3988

Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells

Retraction in: /10.3892/ijo.2024.5679

Authors:
- Hang Li
- Dan Li
- Ning Meng
View Affiliations

Affiliations: Department of General Surgery, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, Zhejiang 310015, P.R. China
Published online on: May 8, 2017 https://doi.org/10.3892/ijo.2017.3988
Pages: 2059-2068

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study investigated the effects of runt-related transcription factor 3 (RUNX3) mediated Notch pathway on the biological behavior of colorectal cancer (CRC) SW260 cells. CRC tissues and para-carcinoma tissues were collected from 182 CRC patients who had undergone surgical treatment between January 2008 and December 2010. Immunohistochemical staining with streptavidin-peroxidase (SP) was used to detect RUNX3, Notch1 and Jagged 1 expression levels. CRC SW260 cells were divided into the following groups: Control group, si-NC group, si-RUNX3 group, DAPT group, si-RUNX3+DAPT group, and si-NC+DAPT group. Expression levels of RUNX3, and Notch signaling related genes were measured by real-time fluorescence quantitative polymerase chain reaction (RT-qPCR) and western blotting in vitro. Besides, MTT, soft agar colony formation, Annexin V-FITC/PI double staining and Transwell were performed to analyze the effects of RUNX3 on cell growth and metastasis. Lower positive expression rate of RUNX3 and higher positive expression rate of Notch1 and Jagged 1 were observed in CRC tissues than those in normal adjacent tissues with a negative correlation, and the expression levels were associated with the differentiation degree, TNM staging, lymph node metastasis and tumor invasion depth (all P<0.05). RUNX3 expression was reduced in si-RUNX3 and si-RUNX3+DAPT group but the expression levels of Notch signaling related genes were markedly increased in si-RUNX3 group or decreased in DAPT and si-NC+DAPT group, as compared with those in the control group (all P<0.05). In addition, the proliferation, colony formation, migration and invasion abilities of SW260 cells were enhanced in si-RUNX3 group but were restricted in DAPT and si-NC+DAPT group, which was contrary to cell apoptosis (all P<0.05). RUNX3 contributes to attenuate the proliferation and metastasis of CRC cells, and promotes cell apoptosis through inhibition of Notch signaling pathway.

View Figures

View References

1	Ohhara Y, Fukuda N, Takeuchi S, Honma R, Shimizu Y, Kinoshita I and Dosaka-Akita H: Role of targeted therapy in metastatic colorectal cancer. World J Gastrointest Oncol. 8:642–655. 2016. View Article : Google Scholar : PubMed/NCBI
2	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
3	ELHadi A, Ashford-Wilson S, Brown S, Pal A, Lal R and Aryal K: Effect of social deprivation on the stage and mode of presentation of colorectal cancer. Ann Coloproctol. 32:128–132. 2016. View Article : Google Scholar : PubMed/NCBI
4	Miyo M, Konno M, Nishida N, Sueda T, Noguchi K, Matsui H, Colvin H, Kawamoto K, Koseki J, Haraguchi N, et al: Metabolic adaptation to nutritional stress in human colorectal cancer. Sci Rep. 6:384152016. View Article : Google Scholar : PubMed/NCBI
5	Xu K, Shen K, Liang X, Li Y, Nagao N, Li J, Liu J and Yin P: MiR-139-5p reverses CD44⁺/CD133⁺-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells. Oncotarget. 7:75118–75129. 2016.PubMed/NCBI
6	Kim HA, Koo BK, Cho JH, Kim YY, Seong J, Chang HJ, Oh YM, Stange DE, Park JG, Hwang D, et al: Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer. J Clin Invest. 122:3248–3259. 2012. View Article : Google Scholar : PubMed/NCBI
7	Bu P, Chen KY, Chen JH, Wang L, Walters J, Shin YJ, Goerger JP, Sun J, Witherspoon M, Rakhilin N, et al: A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. Cell Stem Cell. 12:602–615. 2013. View Article : Google Scholar : PubMed/NCBI
8	Furukawa S, Kawasaki Y, Miyamoto M, Hiyoshi M, Kitayama J and Akiyama T: The miR-1-NOTCH3-Asef pathway is important for colorectal tumor cell migration. PLoS One. 8:e806092013. View Article : Google Scholar : PubMed/NCBI
9	Chen F, Liu X, Bai J, Pei D and Zheng J: The emerging role of RUNX3 in cancer metastasis (Review). Oncol Rep. 35:1227–1236. 2016.
10	Llorca-Cardeñosa MJ, Fleitas T, Ibarrola-Villava M, Peña-Chilet M, Mongort C, Martinez-Ciarpaglini C, Navarro L, Gambardella V, Castillo J, Roselló S, et al: Epigenetic changes in localized gastric cancer: The role of RUNX3 in tumor progression and the immune microenvironment. Oncotarget. 7:63424–63436. 2016.PubMed/NCBI
11	Song XY, Li BY, Zhou EX and Wu FX: The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis. Onco Targets Ther. 9:5339–5347. 2016. View Article : Google Scholar : PubMed/NCBI
12	Suárez-Villanueva S, Ayala-Madrigal ML, Peregrina-Sandoval J, Macías-Gómez N, Ramírez-Ramírez R, Muñiz-Mendoza R, Moreno-Ortiz JM, Centeno-Flores M, Maciel-Gutiérrez V, Cabrales E, et al: RUNX3 gene polymorphisms and haplotypes in Mexican patients with colorectal cancer. Genet Mol Res. 14:15505–15510. 2015. View Article : Google Scholar : PubMed/NCBI
13	Mu WP, Wang J, Niu Q, Shi N and Lian HF: Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer: A meta-analysis. Onco Targets Ther. 7:1237–1245. 2014. View Article : Google Scholar : PubMed/NCBI
14	No authors listed. The Helsinki Declaration of the World Medical Association (WMA). Ethical principles of medical research involving human subjects. Pol Merkur Lekarski. 36:298–301. 2014.In Polish.
15	Wrona A and Jassem J: The new TNM classification in lung cancer. Pneumonol Alergol Pol. 78:407–417. 2010.In Polish.
16	Ribeiro J, Marinho-Dias J, Monteiro P, Loureiro J, Baldaque I, Medeiros R and Sousa H: miR-34a and miR-125b expression in HPV infection and cervical cancer development. BioMed Res Int. 2015:3045842015. View Article : Google Scholar : PubMed/NCBI
17	Liu S, Zheng R, Zhang M, Zhang S, Sun X and Chen W: Incidence and mortality of colorectal cancer in China, 2011. Chin J Cancer Res. 27:22–28. 2015.PubMed/NCBI
18	Gan L, Chen S, Zhong J, Wang X, Lam EK, Liu X, Zhang J, Zhou T, Yu J, Si J, et al: ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancer. PLoS One. 6:e169162011. View Article : Google Scholar : PubMed/NCBI
19	Zhang X, Liu K, Zhang T, Wang Z, Qin X, Jing X, Wu H, Ji X, He Y and Zhao R: Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway. Oncotarget. 8:1541–1554. 2017.
20	Suliman MA, Zhang Z, Na H, Ribeiro AL, Zhang Y, Niang B, Hamid AS, Zhang H, Xu L and Zuo Y: Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family. Int J Mol Med. 38:776–784. 2016.PubMed/NCBI
21	Park J, Kim HJ, Kim KR, Lee SK, Kim H, Park KK and Chung WY: Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma. Oncotarget. 8:9079–9092. 2017.
22	Chen Y, Wang X, Cheng J, Wang Z, Jiang T, Hou N, Liu N, Song T and Huang C: MicroRNA-20a-5p targets RUNX3 to regulate proliferation and migration of human hepatocellular cancer cells. Oncol Rep. 36:3379–3386. 2016.PubMed/NCBI
23	Liu X, Wang L and Guo Y: The association between runt-related transcription factor 3 gene promoter methylation and gastric cancer: A meta-analysis. J Cancer Res Ther. 12(Suppl): 50–53. 2016. View Article : Google Scholar : PubMed/NCBI
24	Li DJ, Shi M and Wang Z: RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway. Thorac Cancer. 7:570–580. 2016. View Article : Google Scholar : PubMed/NCBI
25	Liu H, Yin Y, Hu Y, Feng Y, Bian Z, Yao S, Li M, You Q and Huang Z: miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1. Pathol Res Pract. 212:643–649. 2016. View Article : Google Scholar : PubMed/NCBI
26	Negri FV, Crafa P, Pedrazzi G, Bozzetti C, Lagrasta C, Gardini G, Tamagnini I, Bisagni A, Azzoni C, Bottarelli L, et al: Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer. Future Oncol. 11:3167–3174. 2015. View Article : Google Scholar : PubMed/NCBI
27	Vinson KE, George DC, Fender AW, Bertrand FE and Sigounas G: The Notch pathway in colorectal cancer. Int J Cancer. 138:1835–1842. 2016. View Article : Google Scholar
28	Dai Y, Wilson G, Huang B, Peng M, Teng G, Zhang D, Zhang R, Ebert MP, Chen J, Wong BC, et al: Silencing of Jagged 1 inhibits cell growth and invasion in colorectal cancer. Cell Death Dis. 5:e11702014. View Article : Google Scholar
29	Kodach LL, Jacobs RJ, Heijmans J, van Noesel CJ, Langers AM, Verspaget HW, Hommes DW, Offerhaus GJ, van den Brink GR and Hardwick JC: The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer. Carcinogenesis. 31:1567–1575. 2010. View Article : Google Scholar : PubMed/NCBI
30	Wang L, Li D, Liu Y, Wang Y, Cui J, Cui A and Wu W: Expression of RUNX3 and β-catenin in the carcinogenesis of sporadic colorectal tubular adenoma. Tumour Biol. 35:6039–6046. 2014. View Article : Google Scholar : PubMed/NCBI
31	Kranenburg O: Prometastatic NOTCH signaling in colon cancer. Cancer Discov. 5:115–117. 2015. View Article : Google Scholar : PubMed/NCBI
32	Ranganathan P, Weaver KL and Capobianco AJ: Notch signalling in solid tumours: A little bit of everything but not all the time. Nat Rev Cancer. 11:338–351. 2011. View Article : Google Scholar : PubMed/NCBI
33	Subramaniam MM, Chan JY, Soong R, Ito K, Yeoh KG, Wong R, Guenther T, Will O, Chen CL, Kumarasinghe MP, et al: RUNX3 inactivation in colorectal polyps arising through different pathways of colonic carcinogenesis. Am J Gastroenterol. 104:426–436. 2009. View Article : Google Scholar : PubMed/NCBI
34	Tang H, Li RP, Liang P, Zhou YL and Wang GW: miR-125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway. Oncol Lett. 10:681–686. 2015.PubMed/NCBI
35	Ito K, Lim AC, Salto-Tellez M, Motoda L, Osato M, Chuang LS, Lee CW, Voon DC, Koo JK, Wang H, et al: RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. Cancer Cell. 14:226–237. 2008. View Article : Google Scholar : PubMed/NCBI